Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
6.22
+0.17 (2.81%)
At close: Mar 9, 2026, 4:00 PM EDT
5.90
-0.32 (-5.14%)
After-hours: Mar 9, 2026, 6:16 PM EDT
Puma Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 31.11 | 30.28 | 21.59 | 0 | -29.13 | |
| Depreciation & Amortization | 10.14 | 10.12 | 10.22 | 9.84 | 11.31 | |
| Other Amortization | 0.8 | 1.4 | 1.3 | - | - | |
| Loss (Gain) From Sale of Assets | 0 | - | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | 0.63 | 7 | - | |
| Stock-Based Compensation | 6.94 | 8.25 | 10.25 | 11.83 | 32.63 | |
| Provision & Write-off of Bad Debts | -0.36 | -0.52 | 0.88 | - | -1 | |
| Other Operating Activities | 3.25 | -7.08 | - | 0 | 8.15 | |
| Change in Accounts Receivable | -21.28 | 16.35 | -8.37 | -7.82 | -5.98 | |
| Change in Inventory | 3.21 | -1.64 | -2.55 | 2.58 | -3.66 | |
| Change in Accounts Payable | -0.45 | -1.38 | 0.45 | -4.73 | -0.9 | |
| Change in Other Net Operating Assets | 8.45 | -16.86 | -7.38 | -34.52 | 9.23 | |
| Operating Cash Flow | 41.8 | 38.92 | 27.01 | -15.83 | 20.65 | |
| Operating Cash Flow Growth | 7.41% | 44.09% | - | - | 2571.41% | |
| Capital Expenditures | -0.07 | -0.06 | -0.14 | - | - | |
| Sale (Purchase) of Intangibles | - | - | -12.5 | -7 | - | |
| Investment in Securities | -36.12 | -20.38 | -6.49 | 14.1 | -10.88 | |
| Investing Cash Flow | -36.19 | -20.44 | -19.13 | 7.1 | -10.88 | |
| Long-Term Debt Issued | - | - | - | - | 98.5 | |
| Long-Term Debt Repaid | -44.44 | -33.33 | - | - | -100 | |
| Net Debt Issued (Repaid) | -44.44 | -33.33 | - | - | -1.5 | |
| Issuance of Common Stock | 0.13 | 0.15 | - | 12.5 | - | |
| Other Financing Activities | -0.89 | -0.67 | - | -0.28 | -30.43 | |
| Financing Cash Flow | -45.2 | -33.85 | - | 12.22 | -31.93 | |
| Net Cash Flow | -39.58 | -15.37 | 7.88 | 3.5 | -22.16 | |
| Free Cash Flow | 41.73 | 38.86 | 26.87 | -15.83 | 20.65 | |
| Free Cash Flow Growth | 7.38% | 44.64% | - | - | 2740.44% | |
| Free Cash Flow Margin | 18.27% | 16.86% | 11.40% | -6.94% | 8.16% | |
| Free Cash Flow Per Share | 0.82 | 0.79 | 0.56 | -0.35 | 0.51 | |
| Cash Interest Paid | 5.82 | 10.77 | 11.63 | 10.32 | 10.34 | |
| Cash Income Tax Paid | 1.52 | 1.22 | 0.74 | 0.38 | 0.32 | |
| Levered Free Cash Flow | 30.69 | 29.49 | 1.4 | -1.34 | 8.08 | |
| Unlevered Free Cash Flow | 34.03 | 35.88 | 8.43 | 5.91 | 16.08 | |
| Change in Working Capital | -10.08 | -3.54 | -17.85 | -44.5 | -1.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.